Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 159 publications
Axes of biological variation in diffuse large B cell lymphoma.
Journal: Cancer cell
Published: August 28, 2026
Meta-analysis of survival by phased-variant ctDNA and PET response in large B-cell lymphoma.
Journal: Blood advances
Published: May 05, 2026
Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 13, 2025
Enitociclib (VIP152), venetoclax and prednisone in relapsed or refractory aggressive non-Hodgkin lymphoma.
Journal: British journal of haematology
Published: July 02, 2025
An Assessment of Kinase Selectivity, Enzyme Inhibition Kinetics and in Vitro Activity for Several Bruton Tyrosine Kinase (BTK) Inhibitors.
Journal: ACS pharmacology & translational science
Published: June 10, 2025
The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomas.
Journal: British journal of haematology
Published: March 28, 2025
Phase 2 study of alemtuzumab and dose-adjusted EPOCH-R in relapsed or refractory aggressive B-cell lymphomas.
Journal: Leukemia & lymphoma
Published: February 03, 2025
Axes of biological variation in diffuse large B cell lymphoma.
Journal: Cancer cell
Published: January 06, 2025
Multi-Component, Time-Course screening to develop combination cancer therapies based on synergistic toxicity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 25, 2024
DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features.
Journal: Blood cancer discovery
Published: September 12, 2024
Last Updated: 09/26/2026